The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Mass Spectrometry of Human Leukocyte Antigen Class I Peptidomes Reveals Strong Effects of Protein Abundance and Turnover on Antigen Presentation
Open accessAbstract
HLA class I molecules reflect the health state of cells to cytotoxic T cells by presenting a repertoire of endogenously derived peptides. However, the extent to which the proteome shapes the peptidome is still largely unknown. Here we present a high-throughput mass-spectrometry-based workflow that allows stringent and accurate identification of thousands of such peptides and direct determination of binding motifs. Applying the workflow to seven cancer cell lines and primary cells, yielded more than 22,000 unique HLA peptides across different allelic binding specificities. By computing a score representing the HLA-I sampling density, we show a strong link between protein abundance and HLA-presentation (p < 0.0001). When analyzing overpresented proteins - those with at least fivefold higher density score than expected for their abundance - we noticed that they are degraded almost 3 h faster than similar but nonpresented proteins (top 20% abundance class; median half-life 20.8h versus 23.6h, p < 0.0001). This validates protein degradation as an important factor for HLA presentation. Ribosomal, mitochondrial respiratory chain, and nucleosomal proteins are particularly well presented. Taking a set of proteins associated with cancer, we compared the predicted immunogenicity of previously validated T-cell epitopes with other peptides from these proteins in our data set. The validated epitopes indeed tend to have higher immunogenic scores than the other detected HLA peptides. Remarkably, we identified five mutated peptides from a human colon cancer cell line, which have very recently been predicted to be HLA-I binders. Altogether, we demonstrate the usefulness of combining MS-analysis with immunogenesis prediction for identifying, ranking, and selecting peptides for therapeutic use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Huang, D. W., Sherman, B. T., & Lempicki, R. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.211 · Cited by 35,890
Cox, J., & Mann, M. (2008) · Nature Biotechnology · doi:10.1038/nbt.1511 · Cited by 14,855
Self-citationHuang, D. W., Sherman, B. T., & Lempicki, R. A. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn923 · Cited by 14,108
Universal sample preparation method for proteome analysis
Wiśniewski, J. R., Zougman, A., Nagaraj, N., & Mann, M. (2009) · Nature Methods · doi:10.1038/nmeth.1322 · Cited by 8,352
Self-citationAndromeda: A Peptide Search Engine Integrated into the MaxQuant Environment
Cox, J., Neuhauser, N., Michalski, A., Scheltema, R. A., Olsen, J. V., & Mann, M. (2011) · Journal of Proteome Research · doi:10.1021/pr101065j · Cited by 5,500
Self-citationRappsilber, J., Mann, M., & Ishihama, Y. (2007) · Nature Protocols · doi:10.1038/nprot.2007.261 · Cited by 4,641
Self-citationAllele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules
Falk, K., Rötzschke, O., Stevanovié, S., Jung, G., & Rammensee, H.-G. (1991) · Nature · doi:10.1038/351290a0 · Cited by 2,411
SYFPEITHI: database for MHC ligands and peptide motifs
Rammensee, H. G., Bachmann, J., Emmerich, N. P. N., Bachor, O. A., & Stevanović, S. (1999) · Immunogenetics · doi:10.1007/s002510050595 · Cited by 2,314
Towards a systems understanding of MHC class I and MHC class II antigen presentation
Neefjes, J., Jongsma, M. L. M., Paul, P., & Bakke, O. (2011) · Nature Reviews Immunology · doi:10.1038/nri3084 · Cited by 2,044
The Proteomics Identifications (PRIDE) database and associated tools: status in 2013
Vizcaíno, J. A., Côté, R. G., Csordas, A., Dianes, J. A., Fabregat, A., Foster, J. M., Griss, J., Alpi, E., Birim, M., Contell, J., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1262 · Cited by 1,918
Kulak, N. A., Pichler, G., Paron, I., Nagaraj, N., & Mann, M. (2014) · Nature Methods · doi:10.1038/nmeth.2834 · Cited by 1,719
Self-citationReal-time single-molecule observation of rolling-circle DNA replication
Tanner, N. A., Loparo, J. J., Hamdan, S. M., Jergic, S., Dixon, N. E., & van Oijen, A. M. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp006 · Cited by 1,279
Large-scale validation of methods for cytotoxic T-lymphocyte epitope prediction
Larsen, M. V., Lundegaard, C., Lamberth, K., Buus, S., Lund, O., & Nielsen, M. (2007) · BMC Bioinformatics · doi:10.1186/1471-2105-8-424 · Cited by 982
IMMUNODOMINANCE IN MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I–RESTRICTED T LYMPHOCYTE RESPONSES
Yewdell, J. W., & Bennink, J. R. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.51 · Cited by 944
Properties of MHC Class I Presented Peptides That Enhance Immunogenicity
Calis, J. J. A., Maybeno, M., Greenbaum, J. A., Weiskopf, D., De Silva, A. D., Sette, A., Keşmir, C., & Peters, B. (2013) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003266 · Cited by 923
Michalski, A., Damoc, E., Hauschild, J.-P., Lange, O., Wieghaus, A., Makarov, A., Nagaraj, N., Cox, J., Mann, M., & Horning, S. (2011) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.011015 · Cited by 832
Self-citationLundegaard, C., Lamberth, K., Harndahl, M., Buus, S., Lund, O., & Nielsen, M. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn202 · Cited by 808
Walter, S., Weinschenk, T., Stenzl, A., Zdrojowy, R., Pluzanska, A., Szczylik, C., Staehler, M., Brugger, W., Dietrich, P.-Y., Mendrzyk, R., et al. (2012) · Nature Medicine · doi:10.1038/nm.2883 · Cited by 788
Wiśniewski, J. R., Zougman, A., & Mann, M. (2009) · Journal of Proteome Research · doi:10.1021/pr900748n · Cited by 545
Self-citationGenome-Wide Kinetics of Nucleosome Turnover Determined by Metabolic Labeling of Histones
Deal, R. B., Henikoff, J. G., & Henikoff, S. (2010) · Science · doi:10.1126/science.1186777 · Cited by 471
Making sense of mass destruction: quantitating MHC class I antigen presentation
Yewdell, J. W., Reits, E., & Neefjes, J. (2003) · Nature Reviews Immunology · doi:10.1038/nri1250 · Cited by 445
NetMHCcons: a consensus method for the major histocompatibility complex class I predictions
Karosiene, E., Lundegaard, C., Lund, O., & Nielsen, M. (2012) · Immunogenetics · doi:10.1007/s00251-011-0579-8 · Cited by 396
Structure of Peptides Associated with Class I and Class II MHC Molecules
Engelhard, V. H. (1994) · Annual Review of Immunology · doi:10.1146/annurev.immunol.12.1.181 · Cited by 395
A Quantitative Spatial Proteomics Analysis of Proteome Turnover in Human Cells
Boisvert, F.-M., Ahmad, Y., Gierliński, M., Charrière, F., Lamont, D., Scott, M., Barton, G., & Lamond, A. I. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.011429 · Cited by 387
Analysis of Nucleolar Protein Dynamics Reveals the Nuclear Degradation of Ribosomal Proteins
Lam, Y. W., Lamond, A. I., Mann, M., & Andersen, J. S. (2007) · Current Biology · doi:10.1016/j.cub.2007.03.064 · Cited by 369
Self-citationAcetylation-Mediated Proteasomal Degradation of Core Histones during DNA Repair and Spermatogenesis
Qian, M.-X., Pang, Y., Liu, C. H., Haratake, K., Du, B.-Y., Ji, D.-Y., Wang, G.-F., Zhu, Q.-Q., Song, W., Yu, Y., et al. (2013) · Cell · doi:10.1016/j.cell.2013.04.032 · Cited by 330
Kelstrup, C. D., Young, C., Lavallee, R., Nielsen, M. L., & Olsen, J. V. (2012) · Journal of Proteome Research · doi:10.1021/pr3000249 · Cited by 281
Zehn, D., & Bevan, M. J. (2006) · Immunity · doi:10.1016/j.immuni.2006.06.009 · Cited by 269
Database of T cell-defined human tumor antigens: the 2013 update.
Vigneron, N., Stroobant, V., den Eynde, B. J. V., & van der Bruggen, P. (2013) · Europe PMC (PubMed Central) · Cited by 226
Histone levels are regulated by phosphorylation and ubiquitylation-dependent proteolysis
Singh, R. K., Kabbaj, M.-H. M., Paik, J., & Gunjan, A. (2009) · Nature Cell Biology · doi:10.1038/ncb1903 · Cited by 205
Kotturi, M. F., Scott, I., Wolfe, T., Peters, B., Sidney, J., Cheroutre, H., von Herrath, M. G., Buchmeier, M. J., Grey, H., & Sette, A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.3.2124 · Cited by 205
Exploiting the glioblastoma peptidome to discover novel tumour-associated antigens for immunotherapy
Dutoit, V., Herold-Mende, C., Hilf, N., Schoor, O., Beckhove, P., Bucher, J., Dorsch, K., Flohr, S., Fritsche, J., Lewandrowski, P., et al. (2012) · Brain · doi:10.1093/brain/aws042 · Cited by 201
Mommen, G. P. M., Frese, C. K., Meiring, H. D., van Gaans-van den Brink, J., de Jong, A. P. J. M., van Els, C. A. C. M., & Heck, A. J. R. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1321458111 · Cited by 183
Apcher, S., Daskalogianni, C., Lejeune, F., Manoury, B., Imhoos, G., Heslop, L., & Fåhraeus, R. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1104104108 · Cited by 169
DRiPs solidify: progress in understanding endogenous MHC class I antigen processing
Yewdell, J. W. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.08.001 · Cited by 161
Kinetics of Antigen Expression and Epitope Presentation during Virus Infection
Croft, N. P., Smith, S. A., Wong, Y. C., Tan, C. T., Dudek, N. L., Flesch, I. E. A., Lin, L. C. W., Tscharke, D. C., & Purcell, A. W. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003129 · Cited by 160
Paul, P., van den Hoorn, T., Jongsma, M. L. M., Bakker, M. J., Hengeveld, R. C. C., Janssen, L., Cresswell, P., Egan, D. A., van Ham, S. M., ten Brinke, A., et al. (2011) · Cell · doi:10.1016/j.cell.2011.03.023 · Cited by 160
Simultaneous alignment and clustering of peptide data using a Gibbs sampling approach
Andreatta, M., Lund, O., & Nielsen, M. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts621 · Cited by 158
The MHC I immunopeptidome conveys to the cell surface an integrative view of cellular regulation
Caron, É., Vincent, K., Fortier, M., Laverdure, J., Bramoullé, A., Hardy, M., Voisin, G., Roux, P. P., Lemieux, S., Thibault, P., et al. (2011) · Molecular Systems Biology · doi:10.1038/msb.2011.68 · Cited by 136
Soluble plasma HLA peptidome as a potential source for cancer biomarkers
Bassani‐Sternberg, M., Barnea, E., Beer, I., Avivi, I. M., Katz, T., & Admon, A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1008501107 · Cited by 135
Self-citationBerlin, C., Kowalewski, D. J., Schuster, H., Mirza, N., Walz, J. S., Handel, M., Schmid-Horch, B., Salih, H. R., Kanz, L., Rammensee, H., et al. (2014) · Leukemia · doi:10.1038/leu.2014.233 · Cited by 130
Weinzierl, A. O., Lemmel, C., Schoor, O., Müller, M., Krüger, T., Wernet, D., Hennenlotter, J., Stenzl, A., Klingel, K., Rammensee, H., et al. (2006) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m600310-mcp200 · Cited by 128
Next-generation peptide vaccines for advanced cancer
Yamada, A., Sasada, T., Noguchi, M., & Itoh, K. (2013) · Cancer Science · doi:10.1111/cas.12050 · Cited by 124
Singh‐Jasuja, H., Emmerich, N., & Rammensee, H. (2004) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-003-0480-x · Cited by 124
The Turnover Kinetics of Major Histocompatibility Complex Peptides of Human Cancer Cells
Milner, E., Barnea, E., Beer, I., & Admon, A. (2006) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m500241-mcp200 · Cited by 122
Re-examining class-I presentation and the DRiP hypothesis
Rock, K. L., Farfán-Arribas, D. J., Colbert, J. D., & Goldberg, A. L. (2014) · Trends in Immunology · doi:10.1016/j.it.2014.01.002 · Cited by 120
A catalog of HLA type, HLA expression, and neo-epitope candidates in human cancer cell lines
Boegel, S., Löwer, M., Bukur, T., Şahin, U., & Castle, J. C. (2014) · OncoImmunology · doi:10.4161/21624011.2014.954893 · Cited by 117
The Human Leukocyte Antigen–presented Ligandome of B Lymphocytes
Hassan, C., Kester, M. G. D., de Ru, A. H., Hombrink, P., Drijfhout, J. W., Nijveen, H., Leunissen, J. A. M., Heemskerk, M. H. M., Falkenburg, J. H. F., & van Veelen, P. A. (2013) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m112.024810 · Cited by 111
Impact of genomic polymorphisms on the repertoire of human MHC class I-associated peptides
Granados, D. P., Sriranganadane, D., Daouda, T., Zieger, A., Laumont, C. M., Caron-Lizotte, O., Boucher, G., Hardy, M., Gendron, P., Côté, C., et al. (2014) · Nature Communications · doi:10.1038/ncomms4600 · Cited by 110
Toward a Definition of Self: Proteomic Evaluation of the Class I Peptide Repertoire
Hickman, H. D., Luis, A. D., Buchli, R., Few, S. R., Sathiamurthy, M., VanGundy, R. S., Giberson, C. F., & Hildebrand, W. H. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.5.2944 · Cited by 109
HLA ligandome tumor antigen discovery for personalized vaccine approach
Rammensee, H., & Singh‐Jasuja, H. (2013) · Expert Review of Vaccines · doi:10.1586/14760584.2013.836911 · Cited by 92
Personalized peptide vaccination: a new approach for advanced cancer as therapeutic cancer vaccine
Noguchi, M., Sasada, T., & Itoh, K. (2012) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-012-1379-1 · Cited by 91
Human leukocyte antigens (HLA) associated drug hypersensitivity: consequences of drug binding to HLA
Yun, J. J., Adam, J., Yerly, D., & Pichler, W. J. (2012) · Allergy · doi:10.1111/all.12008 · Cited by 91
The relevance of minor histocompatibility antigens in solid organ transplantation
Dierselhuis, M. P., & Goulmy, E. (2009) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0b013e32832d399c · Cited by 88
MHC I–associated peptides preferentially derive from transcripts bearing miRNA response elements
Granados, D. P., Yahyaoui, W., Laumont, C. M., Daouda, T., Muratore‐Schroeder, T. L., Côté, C., Laverdure, J., Lemieux, S., Thibault, P., & Perreault, C. (2012) · Blood · doi:10.1182/blood-2012-02-412593 · Cited by 77
Engelhard, V. H., Brickner, A. G., & Zarling, A. L. (2002) · Molecular Immunology · doi:10.1016/s0161-5890(02)00096-2 · Cited by 75
Overwijk, W. W., Wang, E., Marincola, F. M., Rammensee, H., & Restifo, N. P. (2013) · Journal for ImmunoTherapy of Cancer · doi:10.1186/2051-1426-1-11 · Cited by 65
Machine learning competition in immunology – Prediction of HLA class I binding peptides
Zhang, G., Ansari, H. R., Bradley, P. H., Cawley, G. C., Hertz, T., Hu, X. S., Jojić, N., Kim, Y., Kohlbacher, O., Lund, O., et al. (2011) · Journal of Immunological Methods · doi:10.1016/j.jim.2011.09.010 · Cited by 56
Origin and plasticity of MHC I-associated self peptides
de Verteuil, D. A., Granados, D. P., Thibault, P., & Perreault, C. (2011) · Autoimmunity Reviews · doi:10.1016/j.autrev.2011.11.003 · Cited by 50
Personalized peptide vaccination in patients with refractory non-small cell lung cancer
Sasada, T. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1351 · Cited by 42
The MHC Motif Viewer: A Visualization Tool for MHC Binding Motifs
Rapin, N., Hoof, I., Lund, O., & Nielsen, M. (2010) · Current Protocols in Immunology · doi:10.1002/0471142735.im1817s88 · Cited by 41
Haen, S. P., & Rammensee, H. (2013) · Current Opinion in Immunology · doi:10.1016/j.coi.2013.03.007 · Cited by 41
Proteome Sampling by the HLA Class I Antigen Processing Pathway
Hoof, I., van Baarle, D., Hildebrand, W. H., & Keşmir, C. (2012) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002517 · Cited by 39
Juncker, A. S., Larsen, M. V., Weinhold, N., Nielsen, M., Brunak, S., & Lund, O. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007448 · Cited by 38
Mouchess, M. L., & Anderson, M. S. (2013) · Current topics in microbiology and immunology · doi:10.1007/82_2013_321 · Cited by 30
Resistance Against Natural Killer Cell Cytotoxicity: Analysis of Mechanisms
Hasenkamp, J., Borgerding, A., Wulf, G. G., Uhrberg, M., Jung, W. E., Dingeldein, S., Trümper, L. H. P., & Glaß, B. (2006) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2006.01803.x · Cited by 30
Personalized peptide vaccination in patients with refractory non-small cell lung cancer
吉山, 康. (2013) · Institutional Repositories DataBase (IRDB) · Cited by 17
Kim, Y., Yewdell, J. W., Sette, A., & Peters, B. (2013) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002884 · Cited by 16
Cited by
Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion
Jhunjhunwala, S., Hammer, C., & Delamarre, L. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-021-00339-z · Cited by 1,490
Jurtz, V., Paul, S., Andreatta, M., Marcatili, P., Peters, B., & Nielsen, M. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1700893 · Cited by 1,470
Personalized vaccines for cancer immunotherapy
Sahin, U., & Türeci, Ö. (2018) · Science · doi:10.1126/science.aar7112 · Cited by 1,147
Gapped sequence alignment using artificial neural networks: application to the MHC class I system
Andreatta, M., & Nielsen, M. (2016) · Bioinformatics · doi:10.1093/bioinformatics/btv639 · Cited by 1,087
A guide to antigen processing and presentation
Pishesha, N., Harmand, T. J., & Ploegh, H. L. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-022-00707-2 · Cited by 805
Metadata
- Authors
- Bassani-Sternberg, M., Pletscher-Frankild, S., Jensen, L. J., & Mann, M.
- Venue
- Molecular & Cellular Proteomics
- Publisher
- Elsevier BV
- Published
- 2015-03
- Volume
- 14
- Issue
- 3
- Pages
- 658-673
- ISSN
- 1535-9476 (ISSN-L)
- OpenAlex
- W2141609931
- Cited by
- 426
- References
- 68
- FWCI
- 14.28
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.